Exact Mass: 466.3294
Exact Mass Matches: 466.3294
Found 88 metabolites which its exact mass value is equals to given mass value 466.3294
,
within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error
0.0002 dalton.
28-Norbrassinolide
28-norbrassinolide belongs to brassinolides and derivatives class of compounds. Those are cholestane based steroid lactones containing benzo[c]indeno[5,4-e]oxepin-3-one. 28-norbrassinolide is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 28-norbrassinolide can be found in tea and turnip, which makes 28-norbrassinolide a potential biomarker for the consumption of these food products.
(3alpha,5beta,7alpha,12alpha)-form-3,7,12,27-Tetrahydroxycholesten-26-oic acid
(24S)-3beta,4beta,6alpha,8,24-pentahydroxy-5alpha-cholestan-15-one|certonardosterol Q2
(3beta, 5alpha, 6alpha, 24E)-Cholest-24-ene-3, 6, 8, 14, 15, 26-hexol, 9CI
O-3-(beta-methyl)valeroyl alpha-bisabolol beta-D-fucopyranoside
(23R,24S)-3beta,11alpha,16beta,23,24-pentahydroxy-5alpha-cholestan-6-one
2-(3-eicosadienoyloxy-2-hydroxypropanoxy)methylpropenoic acid
(2alpha, 3beta, 5alpha, 6beta, 9alpha, 11alpha)-Cholest-7-ene-2, 3, 5, 6, 9, 11-hexol
2beta,3beta,14,20,22,25-hexahydroxy-5-cholest-7-ene
(22E,24R)-5alpha-cholest-22-ene-3beta,4beta,6alpha,8,15beta,24-hexaol
(6R)-2-(hydroxymethyl)-6-((3R,5R,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid
(6R)-3-hydroxy-2-methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid
(6R)-2-methyl-6-((2R,3S,5S,7R,8R,9S,10S,12S,13R,14S,17R)-2,3,7,12-tetrahydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid
(2S,3R,6R)-3-hydroxy-2-methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid
(2R,3R,6R)-3-hydroxy-2-methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid
(2S,3S,6R)-3-hydroxy-2-methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid
(2R,3S,6R)-3-hydroxy-2-methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid
2β,3α,7α,12α-Tetrahydroxy-5β-cholestan-26-oic acid
3α,7α,12α,22-Tetrahydroxy-5β-cholestan-26-oic acid
3α,7α,12α,24-Tetrahydroxy-5α-cholestan-26-oic acid
3α,7α,12α,23-Tetrahydroxy-5β-cholestan-26-oic acid
1β,3α,7α,12α-Tetrahydroxy-5β-cholestan-26-oic acid
3α,6α,7α,12α-Tetrahydroxy-5β-cholestan-26-oic acid
3α,7α,12α,25-Tetrahydroxy-5β-cholestan-26-oic acid
2beta,3alpha,7alpha,12alpha-Tetrahydroxy-5beta-cholestan-26-oic acid
3alpha,7alpha,12alpha,22-Tetrahydroxy-5beta-cholestan-26-oic acid
3alpha,7alpha,12alpha,24-Tetrahydroxy-5alpha-cholestan-26-oic acid
3alpha,7alpha,12alpha,23-Tetrahydroxy-5beta-cholestan-26-oic acid
1beta,3alpha,7alpha,12alpha-Tetrahydroxy-5beta-cholestan-26-oic acid
3alpha,6alpha,7alpha,12alpha-Tetrahydroxy-5beta-cholestan-26-oic acid
3alpha,7alpha,12alpha,25-Tetrahydroxy-5beta-cholestan-26-oic acid
3alpha,7alpha,22S-trihydroxy-5alpha-cholestan-26-oic acid
3alpha,7alpha,12alpha,26-tetrahydroxy-5alpha-cholestan-27-oic acid
(25R)-1beta,3alpha,7alpha,12alpha-tetrahydroxy-5beta-cholestan-26-oic acid
(25S)-2beta,3alpha,7alpha,12alpha-tetrahydroxy-5beta-cholestan-26-oic acid
3alpha,7alpha,12alpha,22S-tetrahydroxy-5beta-cholestan-26-oic acid
(25S)-3alpha,7alpha,12alpha,24R-tetrahydroxy-5beta-cholestan-26-oic acid
(25R)-3alpha,7alpha,12alpha,24R-tetrahydroxy-5beta-cholestan-26-oic acid
(25S)-3alpha,7alpha,12alpha,24S-tetrahydroxy-5beta-cholestan-26-oic acid
(25R)-3alpha,7alpha,12alpha,24S-tetrahydroxy-5beta-cholestan-26-oic acid
3alpha,7alpha,12alpha,26-Tetrahydroxy-5beta-cholestan-27-oic acid
3alpha,7alpha,15alpha,22S-Tetrahydroxy-5beta-cholestan-26-oic acid
3alpha,7alpha,16alpha,22S-Tetrahydroxy-5beta-cholestan-26-oic acid
3alpha,7alpha,16alpha,24R-Tetrahydroxy-5beta-cholestan-26-oic acid
3alpha,7alpha,12alpha,16alpha-Tetrahydroxy-5beta-cholestan-26-oic acid
(24R,25R)-3alpha,7alpha,12alpha,24-Tetrahydroxy-5beta-cholestan-26-oic acid
(2S,3S,6R)-3-hydroxy-2-methyl-6-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid
(6R)-2-methyl-6-((2R,3S,5S,7R,8R,9S,10S,12S,13R,14S,17R)-2,3,7,12-tetrahydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptanoic acid
(24S)-3alpha,7alpha,12alpha,24-tetrahydroxy-5beta-cholestan-26-oic acid
3alpha,7alpha,12alpha,24-tetrahydroxy-5beta-cholestan-26-oic acid with S configuration at C-24.